Skip to main content
STTK
NASDAQ Life Sciences

Shattuck Labs Q2 Loss Widens to $15.2M as R&D Costs Climb; Phase 2b Trial Set for Q3

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$7
Mkt Cap
$645.259M
52W Low
$0.712
52W High
$8.33
52W Position info
883% above low
Off High info
16% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

STTK has more than doubled off its 52-week low of $0.712.

Summary

Shattuck Labs reported a Q2 net loss of $15.15 million, or $0.12 per share, widening from the prior year as R&D spending increased to advance its clinical pipeline. The company ended the quarter with $208.3 million in cash and investments, which it expects to fund operations into 2029. This follows a series of capital raises in June that brought in over $86 million and attracted significant institutional buying. The key new development is the planned initiation of a Phase 2b trial for lead candidate SL-325 in Crohn's disease in Q3 2026, with primary endpoint data expected in the first half of 2028. The wider loss and lack of revenue are typical for a clinical-stage biotech, but the cash runway and upcoming trial start provide a clearer path forward.

At the time of this announcement, STTK was trading at $7.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $645.3M. The 52-week trading range was $0.71 to $8.33. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

STTK - Latest Insights

STTK
Nov 05, 2026, 8:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.50
Real-time Price: $4.10 info
Change: -$1.40 (-25%) info
Market Cap: $450.631M info
STTK
Nov 05, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.50
Real-time Price: $4.10 info
Change: -$1.40 (-25%) info
Market Cap: $450.631M info
STTK
Oct 01, 2026, 7:04 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $6.79
Real-time Price: $4.10 info
Change: -$2.69 (-40%) info
Market Cap: $450.631M info
STTK
Aug 11, 2026, 6:59 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $4.10 info
Change: -$2.90 (-41%) info
Market Cap: $450.631M info
STTK
Aug 11, 2026, 6:57 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $4.10 info
Change: -$2.90 (-41%) info
Market Cap: $450.631M info